Your browser doesn't support javascript.
loading
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group).
Wu, Zhenjie; Chen, Qi; Djaladat, Hooman; Minervini, Andrea; Uzzo, Robert G; Sundaram, Chandru P; Rha, Koon H; Gonzalgo, Mark L; Mehrazin, Reza; Mazzone, Elio; Marcus, Jamil; Danno, Alyssa; Porter, James; Asghar, Aeen; Ghali, Fady; Guruli, Georgi; Douglawi, Antoin; Cacciamani, Giovanni; Ghoreifi, Alireza; Simone, Giuseppe; Margulis, Vitaly; Ferro, Matteo; Tellini, Riccardo; Mari, Andrea; Srivastava, Abhishek; Steward, James; Al-Qathani, Ali; Al-Mujalhem, Ahmad; Bhattu, Amit Satish; Mottrie, Alexander; Abdollah, Firas; Eun, Daniel D; Derweesh, Ithaar; Veccia, Alessandro; Autorino, Riccardo; Wang, Linhui.
Afiliação
  • Wu Z; Department of Urology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Chen Q; Department of Health Statistics, Naval Medical University, Shanghai, China.
  • Djaladat H; Institute of Urology & Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Minervini A; Department of Experimental and Clinical Medicine, University of Florence - Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Uzzo RG; Division of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Sundaram CP; Indiana University School of Medicine, Indianapolis, IN, USA.
  • Rha KH; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Gonzalgo ML; Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Mehrazin R; Icahn School of Medicine at Mount Sinai, Department of Urology, New York, NY, USA.
  • Mazzone E; OLV Hospital, Aalst, Belgium;ORSI Academy, Melle, Belgium.
  • Marcus J; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI, USA.
  • Danno A; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI, USA.
  • Porter J; Swedish Medical Center, Seattle, WA, USA.
  • Asghar A; Department of Urology, Temple University, Philadelphia, PA, USA.
  • Ghali F; Department of Urology, UCSD, San Diego, CA, USA.
  • Guruli G; Division of Urology, VCU Health, Richmond, VA, USA.
  • Douglawi A; Institute of Urology & Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Cacciamani G; Institute of Urology & Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Ghoreifi A; Institute of Urology & Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Simone G; Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.
  • Margulis V; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Ferro M; Division of Urology - European Institute of Oncology, IRCCS.
  • Tellini R; Department of Experimental and Clinical Medicine, University of Florence - Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Mari A; Department of Experimental and Clinical Medicine, University of Florence - Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Srivastava A; Division of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Steward J; Indiana University School of Medicine, Indianapolis, IN, USA.
  • Al-Qathani A; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Al-Mujalhem A; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Bhattu AS; Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Mottrie A; OLV Hospital, Aalst, Belgium;ORSI Academy, Melle, Belgium.
  • Abdollah F; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI, USA.
  • Eun DD; Department of Urology, Temple University, Philadelphia, PA, USA.
  • Derweesh I; Department of Urology, UCSD, San Diego, CA, USA.
  • Veccia A; Division of Urology, VCU Health, Richmond, VA, USA.
  • Autorino R; Division of Urology, VCU Health, Richmond, VA, USA.
  • Wang L; Department of Urology, Changzheng Hospital, Naval Medical University, Shanghai, China. Electronic address: wanglinhui@smmu.edu.cn.
Eur Urol Focus ; 8(1): 173-181, 2022 Jan.
Article em En | MEDLINE | ID: mdl-33549537
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cisplatino / Nefroureterectomia Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur Urol Focus Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cisplatino / Nefroureterectomia Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur Urol Focus Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Holanda